| 注册
首页|期刊导航|中华医学杂志(英文版)|Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness

Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness

Shi Xuehui Wei Wenbin Zhang Cong

中华医学杂志(英文版)2014,Vol.127Issue(12):2279-2285,7.
中华医学杂志(英文版)2014,Vol.127Issue(12):2279-2285,7.DOI:10.3760/cma.j.issn.0366-6999.20140544

Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness

Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness

Shi Xuehui 1Wei Wenbin 2Zhang Cong1

作者信息

  • 1. Beijing Tongren Eye Center,Beijing Tongren Hospital,Capital Medical University
  • 2. Beijing Ophthalmology & Visual Science Key Labratory,Beijing 100730,China
  • 折叠

摘要

关键词

idiopathic choroidal neovascularization/intravitreal ranibizumab injection/photodynamic therapy/visual outcome/retinal thickness/choroidal thickness

Key words

idiopathic choroidal neovascularization/intravitreal ranibizumab injection/photodynamic therapy/visual outcome/retinal thickness/choroidal thickness

引用本文复制引用

Shi Xuehui,Wei Wenbin,Zhang Cong..Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness[J].中华医学杂志(英文版),2014,127(12):2279-2285,7.

基金项目

This study was supported by grants from the National Natural Science Foundation of China (No.81272981) and Natural Sciences Fundation of Beijing,China (No.7112031). (No.81272981)

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量0
|
下载量0
段落导航相关论文